Jubilant Cadista Pharmaceuticals, Inc. recalls

30 recalls on record · latest: December 27, 2022

Official U.S. recall history for Jubilant Cadista Pharmaceuticals, Inc., compiled from official government records.

Get recall alerts

Free email alert whenever Jubilant Cadista Pharmaceuticals, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

Jubilant Cadista Pharmaceuticals, Inc. recalls Prochlorperazine Maleate Tablets, USP 5mg, 100 tablets, RX Only, Jubilant Cadista Pharmaceuticals, Inc., Salisbury, Mar…

December 27, 2022 · Drug & medication recalls Subpotent Drug: Out of specification for assay at the 18-month stability timepo…

Meclizine Hydrochloride Tablets USP recalled over labeling errors

March 8, 2022 · Drug & medication recalls High risk Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labele…

Jubilant Cadista Pharmaceuticals, Inc. recalls Methylprednisolone Tablets USP, 4 MG, packaged in a 21-count blister pack, Rx only, Jubilant Cadista Pharmaceuticals, I…

February 19, 2021 · Drug & medication recalls Labeling: Illegible label: Customer complaint received of mis-alignment print o…

Jubilant Cadista Pharmaceuticals, Inc. recalls Lamotrigine Tablets, USP, 150 mg, 20,000-count bulk container, Manufactured by: Jubilant Cadista Pharmaceuticals Inc.,…

May 26, 2020 · Drug & medication recalls Presence of Foreign Substance visually consistent with the silica granules pres…

Pantoprazole Sodium Delayed-Release Tablets recalled over manufacturing violations

March 11, 2020 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of dark brown discoloration on edges of tablets

Amantadine Hydrochloride Tablets recalled over foreign material

December 2, 2019 · Drug & medication recalls Moderate risk Presence of Foreign Substance: Presence of a foreign object in a single tablet.

Pantoprazole Sodium Delayed Release Tablets recalled over manufacturing violations

September 4, 2019 · Drug & medication recalls Moderate risk CGMP Deviation: Presence of dark brown discoloration on edges of tablets.

Jubilant Cadista Pharmaceuticals Inc. recalls Cadista — Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/ 0.02mg

July 23, 2019 · Drug & medication recalls Due to out of specification (OOS) dissolution results at the 3-month stability…

Jubilant Cadista Pharmaceuticals, Inc. recalls Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/0.02 mg, packaged into a carton containing 3 blister cards each b…

July 9, 2019 · Drug & medication recalls High risk Failed dissolution specifications : failed results at the 3-month stability tim…

Jubilant Cadista Pharmaceuticals, Inc. recalls Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx Only, Manufactured by: Jubilant Generics…

March 29, 2019 · Drug & medication recalls Moderate risk Discoloration: Expansion of an earlier recall due to the presence of dark brown…

Jubilant Cadista Pharmaceuticals, Inc. recalls Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx only, Manufactured by: Jubilant Generics…

October 2, 2018 · Drug & medication recalls Moderate risk Discoloration: Presence of dark discoloration or brown spots on the edges of th…

Jubilant Cadista Pharmaceuticals, Inc. recalls MethylPREDNISolone Tablets, USP, 4 mg, 21-count blister pack. Rx Only. Jubilant Cadista Pharmaceuticals Inc. Salisbury,…

August 27, 2018 · Drug & medication recalls Failed Stability Specifications: An out-of-specification result was obtained du…

Valsartan Tablets USP recalled over undeclared excipient

August 14, 2018 · Drug & medication recalls Incorrect/Undeclared Excipient: There is a potential an incorrect grade of exci…

Valsartan Tablets USP recalled over undeclared excipient

August 14, 2018 · Drug & medication recalls Incorrect/Undeclared Excipient: There is a potential an incorrect grade of exci…

Valsartan Tablets USP recalled over undeclared excipient

August 14, 2018 · Drug & medication recalls Incorrect/Undeclared Excipient: There is a potential an incorrect grade of exci…

Valsartan Tablets USP recalled over undeclared excipient

August 14, 2018 · Drug & medication recalls Incorrect/Undeclared Excipient: There is a potential an incorrect grade of exci…

Valsartan Tablets USP recalled over undeclared excipient

May 25, 2018 · Drug & medication recalls Incorrect/Undeclared excipient: Product batches were released into commercial d…

Jubilant Cadista Pharmaceuticals, Inc. recalls Meclizine hydrochloride tablets USP, 12.5 mg, 100 count HDPE bottle, Rx only, Manufactured by: Jubilant Cadista Pharmac…

October 30, 2017 · Drug & medication recalls Marketed without an approved NDA/ANDA: Bottles were released prior to final app…

Jubilant Cadista Pharmaceuticals, Inc. recalls Methylprednisolone Tablets, USP, 16 mg, 50-count bottles, Rx only, Manufactured by Jubilant Cadista Pharmaceuticals Inc…

June 13, 2016 · Drug & medication recalls Labeling: Incorrect or Missing Lot and/or Exp Date: incorrect expiration date o…

Jubilant Cadista Pharmaceuticals, Inc. recalls BuPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, packaged in a) 60-count bottles (NDC 59746-316-60)…

April 8, 2016 · Drug & medication recalls Failed Impurities/Degradation Specifications: high out of specification results…

Jubilant Cadista Pharmaceuticals, Inc. recalls BuPROPion Hydrochloride Extended-release Tablets, USP (SR), 100 mg, packaged in a) 60-count bottles (NDC 59746-315-60)…

April 8, 2016 · Drug & medication recalls Failed Impurities/Degradation Specifications: high out of specification results…

Jubilant Cadista Pharmaceuticals, Inc. recalls BuPROPion Hydrochloride Extended-release Tablets, USP (SR), 200 mg, packaged in a) 60-count bottles (NDC 59746-317-60)…

April 8, 2016 · Drug & medication recalls Failed Impurities/Degradation Specifications: high out of specification results…